Aug. 8 at 9:45 PM
$NCNA Yes, the volume has been weak lately, but it's been more buying than selling. Remember folks... the FDA clearance of NUC-7738, the Phase Two continuation of NuTide:701 and over 21 million in capital to propel activities into 2029 are all green flags and proof that management isn't asleep at the wheel. August is looking like the month we start the upward trajectory back beyond
$2. Good earnings will no doubt boost things as well.